Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 402,326 | 0.00 | 0 |
1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 10,461 | 0.00 | 0 |
1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 31,822 | 0.00 | 10,461 |
1 Aug 24 | CERE Cerevel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0 | 95,242 | 0.00 | 0 |
12 Jun 24 | DNA Ginkgo Bioworks | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 105,263 | 0.00 | 386,480 |
12 Jun 24 | DNA Ginkgo Bioworks | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 105,263 | 0.00 | 0 |
5 Jun 24 | CERE Cerevel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 10,461 | 0.00 | 42,283 |
16 May 24 | DNA Ginkgo Bioworks | Class A Common Stock | Sell | Dispose S | Yes | No | 0 | 265,000 | 0.00 | 5,515,364 |
14 May 24 | DNA Ginkgo Bioworks | Class A Common Stock | Sell | Dispose S | No | No | 0 | 1,727,056 | 0.00 | 281,217 |